baber/WOPTO huggingface dataset:
Patent CA-2467484-A1 (CA)
Inventor: SHAH REZA H
IPC: H02K7/00
Filed: 2004-05-17
Abstract: A manually operated voltage generating device provides an electrical voltage for operating an electronic unit such as a remote control handheld unit. The device has a permanent magnet mounted in a horizontal manner at the underside of a mild steel plate.  The magnet is normally located in a spaced manner from the central post of an E-shaped core.  A winding is wound on the central post. A compression spring mounted over the core maintains the magnet normally spaced above the core. The mild steel plate is operative in an up and down manner against the spring force of the spring to move the magnet in a reciprocating movement relative to the core so as to generate a current in the winding. The current charges a capacitor, and the voltage across the capacitor provide the electrical voltage for operating the electronic unit.
Patent CA-2467611-A1 (CA)
Title: Azithromycin dosage forms with reduced side effects
Inventor: LYON DAVID KEITH
IPC: A61P31/04
Filed: 2004-05-18
Abstract: An oral dosage form comprising azithromycin and an effective amount of an alkalizing agent. Preferably, said oral dosage form comprises an effective amount of an alkalizing agent and an azithromycin multiparticulate wherein said multiparticulate comprises azithromycin, a mixture of glyceryl monobehenate, glyceryl dibehenate and glyceryl tribehenate, and a poloxamer. Typically, the oral dosage form includes any suitable oral dosing means such as a powder for oral suspension, a unit dose packet or sachet, a tablet or a capsule. Additionally disclosed is an oral suspension comprising azithromycin, an effective amount of an alkalizing agent and a vehicle. Preferably, the azithromycin is in multiparticulate form wherein said multiparticulate comprises azithromycin, a mixture of glyceryl monobehenate, glyceryl dibehenate and glyceryl tribehenate, and a poloxamer. Also disclosed is a method for reducing gastrointestinal side effects, associated with administering azithromycin to a mammal, comprising contiguously administering azithromycin and an effective amount of alkalizing agent to said mammal wherein the frequency of gastrointestinal side effects is lower than that experienced by administering an equal dose of azithromycin without said alkalizing agent. Further disclosed is a method of treating a bacterial or protozoal infection in a mammal in need thereof comprising contiguously administering to said mammal a single dose of an oral dosage form wherein said oral dosage form comprises azithromycin and an effective amount of an alkalizing agent. Additionally disclosed are azithromycin multiparticulates comprising azithromycin, a surfactant; and a pharmaceutically acceptable carrier.
Patent CA-2468150-A1 (CA)
Title: Stabilisation de la viscosite dans des solutions alcalines
Inventor: WINSTON PHILIP E
IPC: C11D3/10
Filed: 2002-11-13
Abstract: L'invention concerne une solution alcaline aqueuse comprenant au moins un caustique et une dose stabilisatrice de viscosité de gomme de diutane.
Patent CA-2468482-A1 (CA)
Title: Solar energy converter and solar energy conversion system
Inventor: AKAMATSU NORIO
IPC: H02N6/00
Filed: 2002-10-16
Abstract: A solar energy converter includes: a light-concentrating instrument; an electron emitter in an insulated vacuum vessel, emitting electrons in a vacuum as a temperature rises by sunlight; an electron accelerator within the light-concentrating instrument; a cathode on a surface of the electron emitter opposite to a surface which is irradiated by sunlight, and electrically connected with the electron emitter; an electric field supplier having a positive terminal and a negative terminal; and an electron collector in the vacuum vessel, collecting the emitted electrons flying from the electron emitter toward the electron accelerator; wherein the electron accelerator is connected with the positive terminal and the cathode is connected with the negative terminal to generate an electric field, and the electron collector is used as a negative generator electrode and the cathode is used as a positive generator electrode in which the collected electrons migrate to the electron emitter to generate electricity.
Patent CA-2470639-A1 (CA)
Title: Preparation for wound healing and prevention of bandage adhesion to the wound
Inventor: RUZICKOVA JANA
IPC: A61L15/28
Filed: 2003-01-15
Abstract: Preparation for wound healing and prevention of adhesion to the wound containing a physiologically acceptable salt of hyaluronic acid, iodine and potassium iodine.
Patent CA-2473116-A1 (CA)
Title: Electronic reader for sterilization monitors
Inventor: HEHENBERGER RODNEY K
IPC: G01N31/22
Filed: 2002-11-18
Abstract: A system for determining the efficacy of a sterilization process and communicating that determination to a remote device. The system includes a sterilization sensor and a reader adapted to receive that sterilization sensor. The sterilization sensor has an indicator that undergoes a predetermined optical change when exposed to a sterilization process. The reader has an illumination source for illuminating the sterilization sensor, a color sensor for evaluating the condition of the illuminated sterilization sensor, and an interpretation circuit for interpreting the output of the color sensor to determine whether the optical change has taken place. The reader also has a communication circuit for communicating data from the interpretation circuit to the remote device. In the preferred embodiments, the sterilization sensor is disposable and the reader is reusable.
Patent CA-2475796-A1 (CA)
Title: Pressure sensor having an optical waveguide, and method for pressure detection
Inventor: REICHINGER GERHARD
IPC: B60J1/00
Filed: 2003-02-10
Abstract: A pressure sensor includes an optical waveguide having an optical fiber with a refractive index n1, located in a fiber guide with a refractive index n3, forming an intermediate region. A medium with a refractive index n2 is located in the intermediate region. The refractive indices correspond to the relation n3 > n1 > n2. When subjected to a pressure, the fiber guide is pressed against the optical fiber such that the condition for the total reflection required for the normal optical waveguidance in the optical waveguide is no longer fulfilled, and attenuation takes place. The attenuation is evaluated in a corresponding control unit. The pressure sensor is especially provided for an anti-pinch device in the motor vehicle industry.
Patent CA-2476422-A1 (CA)
Title: Topiramate salts and compositions comprising and methods of making and using the same
Inventor: PETERSON MATTHEW L
IPC: A61K47/32
Filed: 2003-02-14
Abstract: The invention encompasses novel salts of topiramate, and pharmaceutically acceptable polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, or amorphous forms thereof, as well as pharmaceutical compositions and pharmaceutical unit dosage forms containing the same. In particular, the invention encompasses pharmaceutically acceptable salts of topiramate, including without limitation topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms thereof. The invention further encompasses novel co-crystals or complexes of topiramate, as well as pharmaceutical compositions comprising them. The invention also encompasses methods of treating or preventing a variety of diseases and conditions including, but not limited to, seizures, epileptic conditions, tremors, cerebral function disorders, obesity, neuropathic pain, affective disorders, tobacco cessation, migraines, and cluster headache.
Patent CA-2477491-A1 (CA)
Title: Mww type zeolite substance, precursor substance therefor, and process for producing these substances
Inventor: TSUJI KATSUYUKI
IPC: C01B39/08
Filed: 2003-02-26
Abstract: A process for easily synthesizing a zeolite substance containing an element having a large ionic radius in the framework at a high ratio. This process comprises the following first to fourth steps: First Step: a step of heating a mixture containing a template compound, a compound containing a Group 13 element of the periodic table, a silicon-containing compound and water to obtain a precursor (A); Second Step: a step of acid-treating the precursor (A) obtained in the first step; Third Step: a step of heating the acid-treated precursor (A) obtained in the second step together with a mixture containing a template compound and water to obtain a precursor (B); andFourth Step: a step of calcining the precursor (B) obtained in the third step to obtain a zeolite substance.
Patent CA-2477657-A1 (CA)
Title: Cathepsin cysteine protease inhibitors
Inventor: BLACK CAMERON
IPC: C07C259/10
Filed: 2003-02-28
Abstract: This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
Patent CA-2484736-A1 (CA)
Title: Gallocatechin gallate-containing composition
Inventor: MAEDA MITSURU
IPC: A23L29/00
Filed: 2003-05-12
Abstract: It is intended to provide a safe and highly efficacious antibacterial composition which is to be used in products mainly taken into the human or animal body or employed in the oral cavity such as foods and oral hygienic preparations without damaging the tastes of foods and drinks. The above composition contains gallocatechin gallate as a potentiator for antibacterial catechins. In particular, the antibacterial effects of the antibacterial catechins on bacteria causative of human decay such as Streptococcus mutans are enhanced thereby. The composition can be produced by mixing antibacterial catechins with gallocatechin gallate. Alternatively, it can be produced as a composition containing as the main component an adsorption fraction which is obtained by subjecting a solvent extract of tea leaves to adsorption by a synthetic adsorbent selected from among aromatic synthetic adsorbents and methacrylic synthetic adsorbents.
Patent CA-2486133-A1 (CA)
Title: Formulation d'injection
Inventor: RATHBONE MICHAEL JOHN
IPC: A61P31/10
Filed: 2003-05-16
Abstract: L'invention concerne une formulation parentérale comprenant un ou plusieurs agents gélifiants, un ou plusieurs solvants miscibles à l'eau et un ou plusieurs agents actifs. La suspension a pour but d'administrer un ou plusieurs agents actifs chez un sujet, sous la forme d'un dépôt, ces agents formant un dépôt au moment de l'administration chez le sujet. Le dépôt se disperse pendant un certain temps et un ou plusieurs agents actifs sont libérés pendant cette durée dans le sujet.
Patent CA-2486614-A1 (CA)
Inventor: KHOURY EDWARD JOSEPH
IPC: A47J27/21
Filed: 2004-11-03
Abstract: A kettle is described having a pair of heating elements each connected to a cable with a plug at its end. The two plugs can be inserted into two separate sockets of a wall plug so that each heating element separately receives power from the sockets.
Patent CA-2489538-A1 (CA)
Inventor: WEST RODNEY J
IPC: B29C65/00
Filed: 2003-06-13
Abstract: A field convertible tap-off base for an electrical busway distribution fitting. The field convertible tap-off base includes an AC phase termination side and a field configurable side having first and second configurable electrical terminals. The AC phase termination side provides terminals for connecting three AC phase conductors of a busway electrical distribution system to any one of a number of load bases configured for electrical components such as circuit breakers, switches, fuses, lugs or other special functions. The first and second configurable terminals permit two additional busway electrical conductors to be used for neutral, high current capacity neutral, secondary ground, DC current or other special functions which might be defined in the busway electrical distribution system.
Patent CA-2493238-A1 (CA)
Title: Medical device with high pressure quick disconnect handpiece
Inventor: STAID KEVIN P
IPC: F16L19/02
Filed: 2002-08-08
Abstract: A method and apparatus are provided for quickly connecting a handpiece (400) to a pressurized fluid source (300). A hollow tube on the handpiece (400) is inserted through an aperture in an annular (100) gasket which is held in a chamber (500) in a body. On application of pressurized fluid to the body, the gasket is pressed against the walls of the chamber, and against the tube, thereby channeling the pressurized fluid through the hollow tube. The handpiece is retained in connection with the body by a releasable connector, such as a latch (944). The handpiece can be removed and replaced by releasing and remaking the connection.
Patent CA-2493752-A1 (CA)
Inventor: GENDREAU STEVEN BRIAN
IPC: C12N5/09
Filed: 2003-08-06
Abstract: Human PAPSS genes are identified as modulators of the AXIN pathway, and thus are therapeutic targets for disorders associated with defective AXIN functio n. Methods for identifying modulators of AXIN, comprising screening for agents that modulate the activity of PAPSS are provided.
Patent CA-2494105-A1 (CA)
Inventor: TOKI BRIAN E
IPC: A61K47/48
Filed: 2003-07-31
Abstract: L'invention concerne des conjugués médicament-lieur-ligand dans lesquels un médicament est lié à un ligand par le biais d'une unité lieuse à base de peptides. Dans un mode de réalisation, le ligand est un anticorps. L'invention concerne en outre des composés de médicaments-lieurs et des composés de médicaments, ainsi que des procédés de traitement du cancer, d'une maladie auto-immune ou d'une maladie infectieuse au moyen des composés et compositions selon l'invention.
Patent CA-2495988-A1 (CA)
Title: Methods for producing hydroxyalkyl tropane esters
Inventor: LEWIN ANITA H
IPC: C07D451/10
Filed: 2003-08-21
Abstract: This invention provides a method for preparing a hydroxyalkyl tropane ester, comprising: (a) contacting a tropane and 1,1'-carbonyldiimidazole to produce an activated tropane ester; (b) contacting the activated tropane ester with an excess of an alkanediol to form a reaction mixture; and (c) maintaining the reaction mixture at a temperature and for a sufficient time for the activated tropane ester to react with the alkanediol to form the corresponding hydroxyalkyl tropane ester. This method may be used to produce hydroxyalkyl derivatives of tropanes such as benzoylecgonine, ecgonine and ecgonidine.
Patent CA-2496261-A1 (CA)
Inventor: D ANGELO GIUSEPPE
IPC: B23K26/42
Filed: 2005-02-09
Abstract: A method for controlling the quality of an industrial processes, of the type comprising the steps of: making available one or more reference signals (x ref) relating to the industrial process acquiring one or more real signals (x real), indicative of the quality of said industrial process, comparing said one or more reference signal (x ref) to said one or more real signals (x real) to identify defects in said industrial process. Said method further comprises the operations of: obtaining (100) a real part (I ref) and an imaginary part (R ref) from said reference signal (x ref) obtaining (200) a real part (I real) and an imaginary part (R real) from said real signal (x real) ; computing (101, 102, 103, 104) first comparison dimensions (AC ref, F ref, mF ref, mF ref_med) between said real part (I ref) and said imaginary part (R ref) from said reference signal (x ref) ; computing (201, 202, 203) second comparison dimensions (Ac real, F real, mF real) between said real part (heal) and said imaginary part (R real) from said real Signal (X real) comparing (204, 105, 205) said first comparison dimensions (AC ref, F ref, mF ref, mF ref_med) and second comparison dimensions (AC real, F real, mF real) to obtain time location information (t1, t2, D) associated to the presence of defects (Ga,Gf).
Patent CA-2499218-A1 (CA)
Inventor: GUSTAFSON MICHAEL W
IPC: G16H20/17
Filed: 2003-09-16
Abstract: A drug delivery system is provided for use in a sedation and analgesia system.  The drug delivery system can include a first bolus interface (20), a second bolus interface (25), wherein the second bolus interface (25) appears after the first bolus interface (20), a third bolus interface (60) wherein the third bolus interface(60) can appear after the second bolus interface (25), and a drug delivery display. The first bolus interface (20) asks a user if he or she wants to give the patient a bolus from the drug delivery. If the user answers yes, then the second bolus interface (25) asks the user to confirm the bolus.  The third bolus interface (60) can appear if the bolus is outside a predetermined range flagging the user that the bolus is outside a specific range asking for confirmation to continue. The drug delivery display can show the drug delivery or any other patient statistics.
Patent CA-2501854-A1 (CA)
Title: Injection molding nozzle
Inventor: FIKANI FADI
IPC: B29C45/27
Filed: 2003-09-16
Abstract: A nozzle for an injection molding runner system comprises a nozzle housing having a melt channel through it, a nozzle tip having a tip channel and at least one outlet aperture in communication with the tip channel, and a tip retainer that retains the nozzle tip against the nozzle housing such that the tip channel communicates with the melt channel. The tip retainer is significantly more thermally conductive than the nozzle tip. A nozzle seal that is significantly less thermally conductive than the tip retainer may be fused with the tip retainer, and may be annularly spaced from the nozzle tip.
Patent CA-2502519-A1 (CA)
Inventor: ISLEY REGGALD E
IPC: B62D55/108
Filed: 2005-03-29
Abstract: A suspension for a tracked vehicle includes a bogie wheel assembly which has a pair of bogie wheels mounted to a walking beam. The walking beam is coupled to a body of the vehicle by a transversely-extending arm. The arm may be coupled to the body by a spherical bearing which permits angular rotation in at least two directions. The walking beam is connected to the body by shear members arranged in an inverted-V configuration. The shear members may be elastomeric springs.
Patent CA-2506338-A1 (CA)
Title: Continuously variable transmission fluid comprising spiro bicyclodiphosphite
Inventor: ISHIKAWA MASAHIRO
IPC: C10N40/04
Filed: 2005-05-04
Abstract: A composition suitable for lubricating a continuously variable transmission comprising a lubricating oil containing an ashless dispersant, a spiro bicyclo- diphosphite, a calcium detergent lubricating oil additive, and, optionally, a succinimide friction modifier and an organic mono- or di-hydrogen phosphite.
Patent CA-2509351-A1 (CA)
Inventor: WORRICK CHARLES BRIDGHAM III
IPC: A45D27/29
Filed: 2000-07-24
Abstract: A shaving cartridge storage device has a base member with at least one divider spaced between respective ends thereof and defining at least one package-receiving storage region. The base member defines a rear surface and the package-receiving storage region faces away from the rear surface. One or more sealed packages are each located in a respective package-receiving storage region and are removable from the package-receiving storage region in a direction away from the rear surface. Each sealed package contains a replaceable shaving cartridge including a plastic housing and a plurality of blades, the shaving cartridge being enclosed by the sealed package and removable in unitary form from the package.
Patent CA-2509437-A1 (CA)
Title: Collapsible trap
Inventor: PARKER GEOFFREY A
IPC: A01K69/10
Filed: 2005-06-08
Abstract: Traps, and more particularly collapsible traps used to capture crabs or other live animals. More particularly still, collapsible live animal traps that utilize one or more support members that are stable when assembled, yet easily collapsible.
Patent CA-2516266-A1 (CA)
Title: Methodes impliquant la pde4, compositions et leur criblage pour le traitement de pathologies neurodegeneratives oculaires
Inventor: DESIRE LAURENT
IPC: A61K31/444
Filed: 2004-02-18
Abstract: La présente invention concerne le domaine de la biologie, de la génétique et de la médecine. Elle concerne notamment de nouvelles méthodes pour la détection, la caractérisation et/ou le traitement (ou la prise en charge) de pathologies neurodégénératives. L'invention concerne également des méthodes pour l'identification ou le criblage de composés actifs dans ces pathologies.  L'invention concerne également les composés, gènes, cellules, plasmides ou compositions utiles pour la mise en oeuvre des méthodes ci-dessus. L'invention découle notamment de l'identification du rôle de la phosphodiestérase 4B du récepteur périphérique aux benzodiazépines(PBR) et des récepteurs au GABA de type GABA(A) dans les pathologies neurodégénératives et décrit leur utilisation comme cible ou marqueur thérapeutique, diagnostique ou expérimental de ces désordres.
Patent CA-2516787-A1 (CA)
Inventor: KESSELMAN DAVID
IPC: B65D1/02
Filed: 2004-02-13
Abstract: The invention provides a base structure of a container. The base structure includes a support heel that defines any number of touch points for contact with a horizontal surface. The support heel includes inner and outer portions that merge with the container's corrugated support flute and sidewall, respectively. The base structure also includes a fin that forms the zipper pinch and extends transverse to and intersects corrugations of the corrugated support flute.
Patent CA-2519361-A1 (CA)
Title: Method of screening for target ligands
Inventor: MOALLEMI CIAMAC
IPC: C12Q1/68
Filed: 2004-03-22
Abstract: A general system for screening targets (e.g., biomolecules) is described. The screening can be used to discover compounds that bind to a naturally occurring low activity or inactive state of a target and act as inhibitors of the target function as seen in subsequent biological assays.
Patent CA-2523487-A1 (CA)
Inventor: DIXON CHRISTOPHER G
IPC: A61M25/06
Filed: 2004-04-26
Abstract: A flexible kink-resistant introducer sheath (10). The introducer sheath includes an inner liner (31), a coil (33) and an outer tube (20). The inner liner includes a passageway (30) extending longitudinally therethrough, where a catheter can be advanced through the passageway. The coil (33) has a plurality of turns positioned longitudinally and compression fitted around the inner liner (31), where the turns have a predetermined spacing therebetween.  The outer tube (20) is positioned longitudinally around the coil (33) and the inner liner (31), and is connected to the inner liner through the spaces between the turns. A diameter difference between the inner liner and the catheter is in a range of about 0.0005 to about 0.004 inch (0.013 to about 0.10 mm).
Patent CA-2524025-A1 (CA)
Inventor: IREDALE PHILIP ANDREW
IPC: A61K45/06
Filed: 2004-04-26
Abstract: Pharmaceutical compositions are disclosed for the treatment of obesity, an overweight condition and compulsive overeating. The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotinic receptor partial agonist and a CB-1 receptor antagonist and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.